Clinical Microbiology Reviews

Papers
(The H4-Index of Clinical Microbiology Reviews is 41. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Vaccines and monoclonal antibodies to prevent healthcare-associated bacterial infections314
Extracutaneous sporotrichosis270
Transmission of Infections during Cardiopulmonary Resuscitation170
Wild-type distributions of minimum inhibitory concentrations and epidemiological cut-off values—laboratory and clinical utility169
A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders157
Erratum for Nyaruaba et al., “Digital PCR Applications in the SARS-CoV-2/COVID-19 Era: a Roadmap for Future Outbreaks”134
HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus127
Antibiotic tolerance among clinical isolates: mechanisms, detection, prevalence, and significance127
Progression of antibiotic resistance in Neisseria meningitidis126
Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant106
Intestinal biofilms: pathophysiological relevance, host defense, and therapeutic opportunities106
Membrane Technology for Rapid Point-of-Care Diagnostics for Parasitic Neglected Tropical Diseases101
Viral infections and pathogenesis of glaucoma: a comprehensive review91
Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options90
Emerging hybrid shigatoxigenic and enteropathogenic Escherichia coli serotype O80:H2 in humans and calves89
Review of BCG immunotherapy for bladder cancer85
Henipaviruses: epidemiology, ecology, disease, and the development of vaccines and therapeutics84
Non- faecium non- faecalis enterococci: a review of clinical manifestations, virulence factors, and antimicrobial resistance78
Viral Respiratory Pathogens and Lung Injury76
Evolutionary Pathways and Trajectories in Antibiotic Resistance73
Congenital Syphilis: a Review of Global Epidemiology69
Clonorchiasis and opisthorchiasis: epidemiology, transmission, clinical features, morbidity, diagnosis, treatment, and control65
Bacillus cereus Invasive Infections in Preterm Neonates: an Up-to-Date Review of the Literature62
Neisseria gonorrhoeae vaccines: a contemporary overview62
Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease58
BCG therapy in bladder cancer and its tumor microenvironment interactions58
Diagnosis, Management, and Future Control of Cholera55
The mRNA Vaccine Technology Era and the Future Control of Parasitic Infections54
Rapid and accurate testing for urinary tract infection: new clothes for the emperor53
Aspergillus terreus Species Complex52
COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes52
Trained Immunity as a Preventive Measure for Surgical Site Infections50
Harnessing the host response for precision infectious disease diagnosis48
Lyme borreliosis in Brazil: a critical review on the Baggio–Yoshinari syndrome (Brazilian Lyme-like disease)47
Immunosuppressant imprecision: multidirectional effects on metabolism and microbiome45
Agnostic Sequencing for Detection of Viral Pathogens45
Mobile Oxazolidinone Resistance Genes in Gram-Positive and Gram-Negative Bacteria45
Artemisinin-resistant malaria44
Advances in the Microbiology of Stenotrophomonas maltophilia43
Editorial Board42
Editorial Board41
0.092059135437012